Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
Genetic Technologies Ltd. Will Jump If Its Predictive Tests Are Approved
06:00am, Wednesday, 14'th Apr 2021
Genetic Technologies Ltd. is moving closer to potential approval of distribution of its COVID-19 Risk Test in the U.S.
Genetic Technologies appoints Mike Tonroe as CFO
08:15am, Monday, 12'th Apr 2021
MELBOURNE, Australia, April 12, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), announces the appointment of Michael Tonroe
Genetic Technologies Provides Update on COVID-19 Risk Test Launch
11:15am, Friday, 09'th Apr 2021
MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health busin
GENE Stock Price Increases Over 25% Pre-Market: Why It Happened
05:40am, Wednesday, 03'rd Mar 2021
The stock price of Genetic Technologies Limited (NASDAQ: GENE) is trading at above 25% pre-market. This is why it happened.
Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
09:20am, Friday, 26'th Feb 2021
MELBOURNE, Australia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today a
Genetic Technologies Limited (GENE) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript
10:28pm, Wednesday, 27'th Jan 2021
Genetic Technologies Limited (GENE) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript
Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering
04:00pm, Monday, 25'th Jan 2021
MELBOURNE, Australia, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today a
Why Addex, Genetic Technologies And Obalon Are Moving Today
11:34am, Thursday, 21'st Jan 2021
Genetic Technologies (NASDAQ: GENE) shares are trading higher after the company provided an update on its COVID-19 severity risk test, saying predictive capabilities improved 100% over age and sex alo
Genetic Technologies Announces $6.56 Million Registered Direct Offering
11:30am, Thursday, 21'st Jan 2021
MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today a
GENE Stock Alert: 10 Things to Know About Genetic Technologies As Shares Rocket Higher
10:18am, Thursday, 21'st Jan 2021
Shares of GENE stock are rising on Thursday morning after Genetic Technologies provided a positive update regarding two important initatives. The post GENE Stock Alert: 10 Things to Know About Genetic
GENE Stock Price Increases Over 80% Pre-Market: Why It Happened
09:12am, Thursday, 21'st Jan 2021
The stock price of Genetic Technologies Limited (NASDAQ: GENE) is trading at over 80% pre-market today. This is why it happened.
Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing
07:00am, Thursday, 21'st Jan 2021
MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market
Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report
04:30pm, Monday, 23'rd Nov 2020
MELBOURNE, Australia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce an interview with its
Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19
08:30am, Tuesday, 17'th Nov 2020
MELBOURNE, Australia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr.
Genetic Technologies Announces Closing of $5.1 Million Registered Direct Offering
12:30am, Tuesday, 21'st Jul 2020
MELBOURNE, Australia, July 20, 2020 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests,.
